Latest on Pharmaceutical Industry


Allergan Exercises Option to Acquire Compound from Aptinyx Discovery Platform Under Ongoing Research Collaboration

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced Allergan plc (NYSE: AGN) has exercised its option to acquire drug candida..Read More...

Eurofins Expands Its Biopharmaceutical Products Testing Footprint with an Outsourcing Agreement with Astellas in Japan

Eurofins Scientific, a global leader in biopharmaceutical products testing services, announces that it has signed an outsourcing agreement with Astellas to outsource one of its internal testing laboratories Astellas Anal..Read More...



Treg Directed Therapy for Autoimmune Disorders Summit 2018

Westin Boston Waterfront,
Hanson Wade


World Biosimilar Congress USA 2018

Hilton San Diego Resort and Spa,
Terrapinn Holdings Ltd

Press Releases

Trianni, Inc. and Antibody Solutions Announce Licensing Agreement

Trianni Inc and Antibody Solutions jointly announced that Antibody Solutions has entered into a license agreement with TRIANNI for use of The Trianni Mouse a bestinclass fully humanized transgenic mouse platform to suppo.. Read More...

Acceleron Announces Initiation of PULSAR Phase 2 Trial of Sotatercept in Pulmonary Arterial Hypertension

Acceleron Pharma Inc a leading biopharmaceutical company in the discovery and development of TGFbeta therapeutics to treat serious and rare diseases today announced the initiation of the PULSAR Phase 2 trial of sotaterce.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Aurena Laboratories AB

Aurena Laboratories AB Aurena business model is to offer support brand owners to launch innovative and competitive products with shortest possible time to market We produce the product to companies around the world. Read More...
Magnus Hedman
Director Business Development Marketing